Medical illness and schizophrenia
著者
書誌事項
Medical illness and schizophrenia
American Psychiatric Pub., c2003
大学図書館所蔵 全1件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
The life expectancy of patients with schizophrenia is approximately 20% shorter than that of the general population. Lifestyle choices, effects of medications, poor self-care, barriers to treatmentAall contribute to medical problems that increase the severity of psychopathology, reduce quality of life, and lead to premature death in patients with schizophrenia.
Medical Illness and Schizophrenia examines the links between medical conditions and severe chronic mental illness, with a focus on -The need for better medical assessment and treatment to improve outcomes in patients with schizophrenia -Links between schizophrenia and conditions such as obesity, cardiovascular disease, diabetes, HIV and hepatitis C, endocrine-related disorders, and others -The association between therapy with certain antipsychotics and adverse health outcomes including hyperlipidemia, obesity, and diabetes mellitus -The importance of improving community health services to treat the dual problems of medical and mental illnesses in the schizophrenic population Developed to fill a critical gap in the literature, Medical Illness and Schizophrenia is an important volume for any clinician who encounters patients with chronic severe mental illness. In addition, it serves to underscore the need to provide integrated medical and psychiatric care to this vulnerable population.
目次
Issues surrounding medical care for individuals with schizophrenia: the challenge of dual neglect by patients and the system. Excessive mortality and morbidity associated with schizophrenia. Obesity in patients with schizophrenia. Cardiovascular illness and hyperlipidemia in patients with schizophrenia. Nicotine and tobacco use in schizophrenia. Glucose intolerance and diabetes in schizophrenia. HIV and hepatitis C in patients with schizophrenia. Medical health in aging persons with schizophrenia. Substance use disorders in schizophrenia. Neurological comorbidity and features in schizophrenia. Prolactin- and endocrine-related disorders in schizophrenia. Index.
「Nielsen BookData」 より